Bristol-Myers Squibb is a global Biopharma company committed to a single mission : to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis.
Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development.
Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.
SUPERVISORSenior Director, Value, Access & Pricing ExecutionMultiple Myeloma & LymphomaAs we prepare for numerous in-line and pipeline product launches, we are seeking an Associate Director to join our Global Market Access team (Value Access & Pricing Execution), focussing on the Multiple Myeloma & Lymphoma franchise.
Please note : We have the scope to hire at Director-level, should you have the sufficient experience / knowledge / gravitasUsing your demonstrable experience in pharmaceutical Pricing and Market Access (preferably in the areas of Hematology, Oncology, Immunology or other innovative and complex treatments), you will lead a wide range of activities to demonstrate the value of BMS products in Multiple Myeloma and Lymphoma (MML) as to ensure that patients have timely access to these treatments.
As Director / Associate Director (D-AD), you will lead the implementation of pricing and market access (P&MA) strategies for BMS in-line brands Revlimid, Pomalyst / Imnovid and Empliciti (including new combination indications).
Working closely with global VAP strategy leads and cross-functional colleagues, you will prepare and support affiliates in the execution of P&MA strategies )from starting 12 months pre-launch and extending through the product lifecycle).
Part of your remit will be to ensure the successful and sustainable affiliate implementation of P&MA strategies as to maximize commercial opportunity - this includes on-time patient accessand appropriate readiness for each new indication.
You will also play a key role in the launch and lifecycle management event,effective engagement and insight exchange between global and affiliate teams (as to inform business decisions and drive functional performance at all levels).
We are seeking you to directly engage with core and extended market affiliates outside of the USA, including Western Europe, Canada and Japan.
Rest-of World markets are indirectly supported through the VAP Intercontinental team. DutiesSupport strategy development by global VAP teamInput to MML portfolio (IMiD, CelMoD) and product strategy (e.
g. value proposition development), championing extended market affiliate perspectives as neededIdentify data gaps and evidence generation needs, working with VAP Strategy, HEOR and Medical Affairs to strengthen value propositions as the competitive environment evolvesMonitor market and competitive pricing and access developments to shape the development of pricing and contracting strategies, including early access programs.
Create and manage VAP execution tools, structures and processesPrepare and update VAP management and reporting tools (e.g.
Business Case Tracker) for progress tracking, interacting with VAP Strategy, HEOR and affiliate leadsOversee regular reporting on VAP performance vs.
pricing and access targets and frameworks, working closely with VAP Analytics teams Understand and deliver insight to meet affiliate key success factors for launch (product value proposition, value package, environment shaping, competitive landscape)Disseminate value packages to in-line with affiliate timing needsPlan, organize and execute affiliate training sessions (e.
g. disease, treatments, competitors, clinical value, value proposition, negotiation).Drive VAP strategy executionDevelop pricing frameworks and annual price targets in collaboration with the Worldwide Pricing team and MML Pricing Analytics leads, including floors, clusters and access scheme models (e.
g. innovative managed entry agreements)Optimize launch sequencing, assessing price-volume trade-offs and price referencing implications, identifying opportunities to accelerate or delay launchesReview HTA submission strategy and list / net pricing for priority markets prior to submissionSupport affiliate business cases for pricing framework exceptions, in collaboration with MML Pricing Analytics leadsInput into business planning (short-, mid- and long-term) and ongoing analytics (e.
g. reference pricing simulations, scenario analyses), with MML Pricing Analytics leads.The D-AD is part of both the worldwide MML VAP Execution and the Hematology WW Pricing and Execution teams.
The D-AD is expected to identify and apply best practices from other products or therapy areas and engage affiliates, considering synergies with other products.
ability to speak another language appreciated.VAP competencies required>
5 years’ experience in Market Access, Pricing and Commercial roles in international and affiliate teams with deep international knowledgeCurrent pricing & reimbursement knowledge of the major markets and the requirements to achieve successful results in each (Western Europe, Japan, Canada)Understanding of the dynamics, potential and trends in managed entry agreements, contracting, reference pricing and pricing conditions (e.
g. orphan incentives)Collaborative negotiation skills with experience putting VAP strategies into practiceKey collaborations and interactionsSuccess in this role depends on the ability to work closely and efficiently with key partnersAffiliate VAP therapy area and product leadsGlobal VAP strategy, HEOR and pricing leadsCross-functional colleagues, especially Commercial, Medical Affairs and RegulatoryThe D-AD will also contribute on an ad-hoc basis to VAP initiatives outside of the specific product and therapy area.
Performance measurementContribution to strategy developmentInteraction with affiliates and cross-functional teamsAffiliate launch readiness and launch executionAccomplishment of MM VAP targets (pricing and access)Achievement of personal goals.
Travel : Travel within Europe and internationally, estimated 30% of working time.Bristol-Myers Squibb recognizes the importance of balance and flexibility in our work environment.
We offer a wide variety of competitive benefits, services and programs that provide our employees the resources to pursue their goals, both at work and in their personal lives.Full time